As we know, cancer is an important disease threatening human health. According to the latest statistics in “Global Cancer Statistics 2020”, cancer is expected to overtake cardiovascular disease as the leading cause of premature death in most countries this century. That sounds pretty terrible, but it is believed that this situation should be better along with the advances in tumor biology. There is no doubt that biomarkers have very significant clinical implications, which can be used for early diagnosis, monitoring progress, and predicting the prognosis of cancer.
In this Research Topic, we focus on the keyword “cancer biomarkers”: (1) the discovery of cancer biomarkers (including new analyzing methods, new molecules or proteins, and association with new cancer types); (2) the biological properties of cancer biomarkers; (3) the mechanisms of action, and biological implications of cancer biomarkers; (4) biomarkers-based chemotherapy and biotherapy. In addition to conventional methods, some state-of-the-art tools or conceptions like proteomics, gene editing like CRISPR-Cas9, PROTAC, bioinformatics, machine learning or artificial intelligence (AI), and single-cell sequencing contribute to the discovery and understanding of cancer biomarkers. Especially, the role of cancer biomarkers for clinical cancer prevention and therapy is worthy of deep exploration. We welcome the submission of original research and review papers from all over the world.
Typical interests, including but not limited to:
• Discovery of cancer biomarkers
• Predictivity or functions of cancer biomarkers in the clinical setting
• Cancer diagnosis based on biomarkers
• Cancer prognosis based on biomarkers
• Molecular mechanisms and biological properties of cancer biomarkers
• Biomarkers-based cancer chemotherapy and biotherapy
• New conceptions, methods, or tools related to cancer biomarkers
As we know, cancer is an important disease threatening human health. According to the latest statistics in “Global Cancer Statistics 2020”, cancer is expected to overtake cardiovascular disease as the leading cause of premature death in most countries this century. That sounds pretty terrible, but it is believed that this situation should be better along with the advances in tumor biology. There is no doubt that biomarkers have very significant clinical implications, which can be used for early diagnosis, monitoring progress, and predicting the prognosis of cancer.
In this Research Topic, we focus on the keyword “cancer biomarkers”: (1) the discovery of cancer biomarkers (including new analyzing methods, new molecules or proteins, and association with new cancer types); (2) the biological properties of cancer biomarkers; (3) the mechanisms of action, and biological implications of cancer biomarkers; (4) biomarkers-based chemotherapy and biotherapy. In addition to conventional methods, some state-of-the-art tools or conceptions like proteomics, gene editing like CRISPR-Cas9, PROTAC, bioinformatics, machine learning or artificial intelligence (AI), and single-cell sequencing contribute to the discovery and understanding of cancer biomarkers. Especially, the role of cancer biomarkers for clinical cancer prevention and therapy is worthy of deep exploration. We welcome the submission of original research and review papers from all over the world.
Typical interests, including but not limited to:
• Discovery of cancer biomarkers
• Predictivity or functions of cancer biomarkers in the clinical setting
• Cancer diagnosis based on biomarkers
• Cancer prognosis based on biomarkers
• Molecular mechanisms and biological properties of cancer biomarkers
• Biomarkers-based cancer chemotherapy and biotherapy
• New conceptions, methods, or tools related to cancer biomarkers